Search Results for keywords:"hearing request"

Found 48 results
Skip to main content

Search Results: keywords:"hearing request"

  • Type:Notice
    Citation:90 FR 13508
    Reading Time:about 2 minutes

    The Securities and Exchange Commission (SEC) published a notice about an application by Goldman Sachs Private Credit Corp. and Goldman Sachs Asset Management, L.P. The applicants are seeking an exemption from certain sections of the Investment Company Act of 1940 to allow certain registered closed-end investment companies to issue different classes of shares with varying fees. The SEC indicates that unless a hearing is requested by April 14, 2025, an order granting the requested relief will be issued. Interested parties can find more details by accessing the applicant's amended application on the SEC's EDGAR system.

    Simple Explanation

    Goldman Sachs asked for a special permission, like a hall pass, from the SEC to use different types of shares that come with different fees. The SEC will allow this unless someone asks for a meeting to talk about it by April 14, 2025.

  • Type:Notice
    Citation:86 FR 5283
    Reading Time:about 6 minutes

    The Securities and Exchange Commission (SEC) has published a notice regarding an application for an order under the Investment Company Act of 1940. The order would grant exemptions from certain sections of the Act and a rule under it, allowing ActiveShares ETFs to issue and redeem shares in large batches, and facilitate market transactions at negotiated prices. The application involves the ActiveShares ETF Trust, Legg Mason Partners Fund Advisor, LLC, and Legg Mason Investor Services, LLC, seeking relief consistent with a prior order. The SEC will issue the order unless someone requests a hearing by February 8, 2021, by contacting the SEC via email.

    Simple Explanation

    The SEC is thinking about letting a special kind of fund, called ActiveShares ETFs, do things differently from normal rules, like trading in big amounts all at once to make buying and selling easier. If anyone wants to say "wait, let's talk about this," they have until February 8, 2021, to tell the SEC by email.

  • Type:Notice
    Citation:86 FR 9540
    Reading Time:about a minute or two

    Siegfried USA, LLC, located in New Jersey, has submitted an application to become an importer of specific controlled substances, as noted by the Drug Enforcement Administration (DEA). The company plans to import these substances to create active pharmaceutical ingredients for its clients, specifically using Phenylacetone to produce Amphetamine. Comments or objections regarding this application are invited by March 18, 2021, and requests for a hearing can also be made by this date. Final permit approval will align with conditions outlined under the relevant U.S. Code and does not permit the commercial import of drug forms approved or non-approved by the Food and Drug Administration (FDA).

    Simple Explanation

    Siegfried USA, LLC wants permission from the government to bring special ingredients into the country to make medicine for their customers. People can say if they think it's a good or bad idea by a certain date, but it's important that these ingredients are used safely and not for anything bad.

  • Type:Notice
    Citation:90 FR 3254
    Reading Time:about 17 minutes

    The U.S. Nuclear Regulatory Commission (NRC) is considering requests to amend the licenses for the Palo Verde Nuclear Generating Station in Arizona. These amendments are proposed to not involve any significant hazards and are open for public comment until February 13, 2025. If interested, people can also request a hearing or submit a petition by March 17, 2025. Additionally, there are procedures to access certain sensitive information related to the amendments for those preparing to contest in a hearing.

    Simple Explanation

    The U.S. Nuclear Regulatory Commission is thinking about changing some rules for a power plant in Arizona with three big nuclear reactors. They want to make sure that these changes are safe and are asking people to share their thoughts or ask for a meeting to talk about it, while explaining how to get special information to help with those discussions.

  • Type:Notice
    Citation:86 FR 8047
    Reading Time:about 5 minutes

    The U.S. Nuclear Regulatory Commission (NRC) has received an application from the Department of Energy National Nuclear Security Administration (DOE/NNSA) seeking approval to export high enriched uranium to France. The notice invites the public to submit comments, request a hearing, or file a petition to intervene by March 5, 2021. The application can be accessed online, and instructions for obtaining further information and commenting are provided. The NRC emphasizes not including sensitive personal information in public submissions and outlines the process for requesting digital access to participate in the proceedings.

    Simple Explanation

    The U.S. is thinking about sending some special uranium to France, and they want people to say if they think it's okay or not by March 5, 2021. They're also letting people know how they can join in and talk about it, but the details are a bit tricky to understand.

  • Type:Notice
    Citation:90 FR 4821
    Reading Time:about 30 minutes

    The Securities and Exchange Commission (SEC) has issued a notice regarding a request for an order to allow certain joint investments. These investments involve business development companies and closed-end management investment companies working together with affiliated investment entities to invest in portfolio companies. The application was initially filed in April 2024, with amendments in October and December 2024. The SEC will grant the order unless a hearing is arranged, and individuals interested in requesting a hearing must do so by February 5, 2025. Further details can be found on the SEC's website or by contacting Taylor Evenson or Terri Jordan at the Division of Investment Management.

    Simple Explanation

    The SEC is saying that some groups want permission to work together to put money into companies, and if no one objects by February 5, 2025, they'll let them. They didn't explain much about why this is okay or how it helps people who might invest, so it might be hard to understand what's going on.

  • Type:Notice
    Citation:90 FR 11997
    Reading Time:about a minute or two

    Fisher Clinical Services, Inc. has applied to the Drug Enforcement Administration to be registered as an importer of certain controlled substances. The purpose of this registration is solely for use in clinical trials, and not for the commercial sale of the substances. The public can submit comments or request a hearing about this application until April 14, 2025. Comments must be submitted electronically, and hearings can be requested in writing, with specific addresses provided for these submissions.

    Simple Explanation

    Fisher Clinical Services wants permission from the government to bring special medicines into the country, but only to use them for testing, not selling. People have time until April 14, 2025, to tell the government what they think about this or ask for a chat about it.

  • Type:Notice
    Citation:86 FR 2460
    Reading Time:about 18 minutes

    The U.S. Nuclear Regulatory Commission (NRC) is considering a request to amend the operating license for the Donald C. Cook Nuclear Plant, Unit No. 2, located in Michigan. This amendment would allow a one-time extension of the current 15-year interval for the plant's integrated leak rate test by about 18 months, extending it until the startup following the fall 2022 refueling. The NRC has determined that this proposed change does not significantly increase safety risks and is seeking public feedback on this assessment. Interested parties have the opportunity to comment, request a hearing, or intervene in the process through established procedures.

    Simple Explanation

    The power company wants to wait a little longer before doing a big safety test on their nuclear plant because they think it's still safe, and they want to hear what people think about this idea. The government is asking people to share their thoughts if they want to.

  • Type:Notice
    Citation:86 FR 3197
    Reading Time:less than a minute

    Siemens Healthcare Diagnostics Inc. has submitted an application to the Drug Enforcement Administration to become a bulk manufacturer of certain controlled substances. The company intends to use these substances to produce products that are exempt from DEA regulations. Individuals or existing registered manufacturers can express their support or objections in writing by March 15, 2021, or request a hearing regarding this application by the same date.

    Simple Explanation

    Siemens Healthcare Diagnostics Inc. wants to make certain special medicines, and they have asked for permission from a group that checks if it's okay. People who have thoughts or worries about this can write to the group or ask to talk with them by March 15, 2021.

  • Type:Notice
    Citation:90 FR 12195
    Reading Time:about 2 minutes

    The Securities and Exchange Commission (SEC) is considering an application from several investment companies and entities for an order that would allow them to make certain joint investments that are usually not allowed under existing rules. The order would permit closed-end management investment companies and business development companies to work together on investments in portfolio companies. This application was submitted in July 2024 and has been revised multiple times, most recently on March 3, 2025. Interested individuals can request a hearing regarding this matter by contacting the SEC and the involved parties by April 7, 2025.

    Simple Explanation

    The SEC is thinking about letting some companies team up to invest together in things they normally couldn't, like people working together on a big project. They're deciding if this is okay, and people can tell the SEC if they have thoughts about it by April 7, 2025.

123 Next